Short CommunicationAntiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay
Section snippets
Acknowledgements
We thank A∗STAR Biomedical Research Council for financial support, Dr. Priscilla Yang (Harvard Medical School) for the HuH-7 cells, the Singapore Environmental Health Institute, National Environment Agency, for the CHIKV and Dr. Xing Jie (Shimadzu, Singapore) for mass spectrometry support. This study was supported by Dr Justin Chu’s MINDEF DIRP Grant R182-000-210-232.
References (32)
- et al.
Dengue virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain
Virology
(1993) - et al.
Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites
Biochem. Biophys. Res. Commun.
(2005) - et al.
Co-translational membrane insertion of the serine proteinase precursor NS2B-NS3(pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B
J. Biol. Chem.
(1997) - et al.
High throughput artificial membrane permeability assay for blood-brain barrier
Eur. J. Med. Chem.
(2003) - et al.
Identification and characterization of non-substrate based inhibitors of the essential dengue and West Nile virus proteases
Bioorg. Med. Chem.
(2005) - et al.
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target
Antiviral Res.
(2008) - et al.
Ten years of dengue drug discovery: progress and prospects
Antiviral Res.
(2013) - et al.
Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases
Bioorg. Med. Chem.
(2011) - et al.
Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease
Antiviral Res.
(2012) - et al.
Strategies for development of dengue virus inhibitors
Antiviral Res.
(2010)
Structural biology of dengue virus enzymes: towards rational design of therapeutics
Antiviral Res.
Role of host cell factors in flavivirus infection: implications for pathogenesis and development of antiviral drugs
Antiviral Res.
Arginine mimetics
Tetrahedron
Dengue and other emerging flaviviruses
J. Infect.
Structure-based discovery of dengue virus protease inhibitors
Antiviral Res.
Anthracene-based inhibitors of dengue virus NS2B-NS3 protease
Antiviral Res.
Cited by (40)
Novel reverse genetics of genotype I and III Japanese encephalitis viruses assembled through transformation associated recombination in yeast: The reporter viruses expressing a green fluorescent protein for the antiviral screening assay
2022, Antiviral ResearchCitation Excerpt :Dihydroartemisinin and Digitonin, inhibited the binding of ZIKV or their entry into host cells (Zhang et al., 2021). ARDP0006 exerted its suppression effect on DENV by interfering with the protease activity of DENV NS2B-NS3 (Chu et al., 2015; Constant et al., 2018). BHK-21 cells respectively infected with GI and GIII reporter viruses at an MOI of 0.1 were treated with these four compounds at different concentrations.
Recent advances of quinones as a privileged structure in drug discovery
2021, European Journal of Medicinal ChemistryA short survey of dengue protease inhibitor development in the past 6 years (2015–2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases
2021, Bioorganic and Medicinal ChemistryExploiting the unique features of Zika and Dengue proteases for inhibitor design
2019, BiochimieCitation Excerpt :Surprisingly, the NS3 internal intrahelicase site and NS3-NS4A junction also are exclusively processed in cis [136]. ARDP0006 (1,8-dihydroxy-4,5-dinitroanthraquinone) has been reported as an active-site Dengue protease inhibitor that blocks production of Dengue 2 virus in tissue culture at low micromolar concentrations [136,137]. However, in an assay with a fluorogenic substrate and the purified protease gDenPro (harbouring the hydrophilic part of NS2B, an uncleavable linker and NS3 protease), ARDP0006 appeared to be a 100-fold weaker inhibitor than tissue culture experiments had suggested [138].
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
2019, Bioorganic and Medicinal Chemistry